Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses
Authors
Keywords
-
Journal
ARTHRITIS AND RHEUMATISM
Volume 63, Issue 8, Pages 2445-2455
Publisher
Wiley
Online
2011-04-12
DOI
10.1002/art.30392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low-Dose Targeted Complement Inhibition Protects against Renal Disease and Other Manifestations of Autoimmune Disease in MRL/lpr Mice
- (2014) C. Atkinson et al. JOURNAL OF IMMUNOLOGY
- Therapeutic effect of artemisinin on lupus nephritis mice and its mechanisms
- (2010) X. Wu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- A Pilot Study of the Therapeutic Efficacy and Mechanism of Artesunate in the MRL/lpr Murine Model of Systemic Lupus Erythematosus
- (2010) Ouyang Jin et al. Cellular & Molecular Immunology
- Cutting Edge: IL-23 Receptor Deficiency Prevents the Development of Lupus Nephritis in C57BL/6-lpr/lpr Mice
- (2010) V. C. Kyttaris et al. JOURNAL OF IMMUNOLOGY
- SM905, an artemisinin derivative, inhibited NO and pro-inflammatory cytokine production by suppressing MAPK and NF-κB pathways in RAW 264.7 macrophages
- (2009) Jun-xia Wang et al. ACTA PHARMACOLOGICA SINICA
- Plasticity of CD4+ T Cell Lineage Differentiation
- (2009) Liang Zhou et al. IMMUNITY
- SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo
- (2009) Li-Fei Hou et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Role of IL-23/IL-17 Axis in Lupus Nephritis
- (2009) Z. Zhang et al. JOURNAL OF IMMUNOLOGY
- MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis
- (2009) Changsheng Du et al. NATURE IMMUNOLOGY
- Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus
- (2009) Agnès Doreau et al. NATURE IMMUNOLOGY
- Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells
- (2008) Véronique Parietti et al. ARTHRITIS AND RHEUMATISM
- The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses
- (2008) J-X Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Regulatory T Cells and Immune Tolerance
- (2008) Shimon Sakaguchi et al. CELL
- Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity
- (2008) Chun Kwok Wong et al. CLINICAL IMMUNOLOGY
- γδ T cells: an important source of IL-17
- (2008) Christina L Roark et al. CURRENT OPINION IN IMMUNOLOGY
- Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation
- (2007) J-X Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now